Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 4
2013 2
2014 4
2015 3
2016 5
2017 3
2018 1
2019 2
2021 3
2022 5
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Sodium zirconium cyclosilicate and metabolic acidosis: Potential mechanisms and clinical consequences.
Fernandez-Prado R, Villalvazo P, Avello A, Gonzalez-de-Rivera M, Aguirre M, Carrasco-Muñoz CG, Fernandez-Fernandez B, Martin-Cleary C, Carriazo S, Sanchez-Niño MD, Perez-Gomez MV, Ortiz A. Fernandez-Prado R, et al. Among authors: martin cleary c. Biomed Pharmacother. 2023 Feb;158:114197. doi: 10.1016/j.biopha.2022.114197. Epub 2023 Jan 4. Biomed Pharmacother. 2023. PMID: 36916426 Free article. Review.
CXCL16 in kidney and cardiovascular injury.
Izquierdo MC, Martin-Cleary C, Fernandez-Fernandez B, Elewa U, Sanchez-Niño MD, Carrero JJ, Ortiz A. Izquierdo MC, et al. Among authors: martin cleary c. Cytokine Growth Factor Rev. 2014 Jun;25(3):317-25. doi: 10.1016/j.cytogfr.2014.04.002. Epub 2014 May 2. Cytokine Growth Factor Rev. 2014. PMID: 24861945 Review.
Haematuria: the forgotten CKD factor?
Moreno JA, Martín-Cleary C, Gutiérrez E, Rubio-Navarro A, Ortiz A, Praga M, Egido J. Moreno JA, et al. Among authors: martin cleary c. Nephrol Dial Transplant. 2012 Jan;27(1):28-34. doi: 10.1093/ndt/gfr749. Nephrol Dial Transplant. 2012. PMID: 22287699 Review.
Designing drugs that combat kidney damage.
Ramos AM, González-Guerrero C, Sanz A, Sanchez-Niño MD, Rodríguez-Osorio L, Martín-Cleary C, Fernández-Fernández B, Ruiz-Ortega M, Ortiz A. Ramos AM, et al. Among authors: martin cleary c. Expert Opin Drug Discov. 2015 May;10(5):541-56. doi: 10.1517/17460441.2015.1033394. Epub 2015 Apr 3. Expert Opin Drug Discov. 2015. PMID: 25840605 Review.
Mitochondria-targeted therapies for acute kidney injury.
Tábara LC, Poveda J, Martin-Cleary C, Selgas R, Ortiz A, Sanchez-Niño MD. Tábara LC, et al. Among authors: martin cleary c. Expert Rev Mol Med. 2014 Aug 8;16:e13. doi: 10.1017/erm.2014.14. Expert Rev Mol Med. 2014. PMID: 25104110 Review.
Translational value of animal models of kidney failure.
Ortiz A, Sanchez-Niño MD, Izquierdo MC, Martin-Cleary C, Garcia-Bermejo L, Moreno JA, Ruiz-Ortega M, Draibe J, Cruzado JM, Garcia-Gonzalez MA, Lopez-Novoa JM, Soler MJ, Sanz AB; Red de Investigacion Renal (REDINREN) and Consorcio Madrileño para investigación del fracaso renal agudo (CIFRA). Ortiz A, et al. Among authors: martin cleary c. Eur J Pharmacol. 2015 Jul 15;759:205-20. doi: 10.1016/j.ejphar.2015.03.026. Epub 2015 Mar 24. Eur J Pharmacol. 2015. PMID: 25814248 Review.
37 results